RxDoctor Payments Data

Abby Buchman, PA

Physician Assistant · Va Beach, VANPI 1700514049

Payments from drug & device makers

$3,057in general payments, 2019–2025

Across 89 payments — averaging $34.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Fortis Surgical, LLC$918
  • Arthrex$551
  • Johnson & Johnson$278
  • AbbVie$225
  • GSK$163
  • AstraZeneca$158
  • plus $764 from 15 others

What the payments were for

  • Travel & lodging$80526%
  • Food & beverage$2,22773%
  • Education$251%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,057 in reported general payments places this provider in the 85th percentile of 3,376 physician assistant providers in Virginia.

See all physician assistant providers in Virginia

Medicare billing

Part B allowed, 2024
$34,002
Medicare patients
211
Services billed
758

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide24$34,701
TrulicityDulaglutide23$30,864
JardianceEmpagliflozin18$24,336
FarxigaDapagliflozin Propanediol27$19,884
EliquisApixaban25$19,017
JanuviaSitagliptin Phosphate18$17,160
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$13,464
Tresiba Flextouch U-100Insulin Degludec14$11,529
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog15$2,881
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$1,646
NystopNystatin12$889
Oxybutynin Chloride ErOxybutynin Chloride13$759
Chlorthalidone35$733
Omeprazole41$710
Rosuvastatin Calcium70$641

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$126$34,70124 claims
Lilly USA, LLCTrulicity$17$30,86423 claims
Boehringer IngelheimJardiance$46$24,33618 claims
AstraZenecaFarxiga$158$19,88427 claims
PfizerEliquis$26$19,01725 claims
GSKTrelegy Ellipta$163$13,46417 claims
AbbVieSynthroid$225$45012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,376 physician assistant providers in Virginia.

Other physician assistant in Va Beach

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →